Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127189) titled 'A Single-Arm, Open-Label, Prospective Phase I Clinical Study to Evaluate the Safety and Preliminary Efficacy of WSK-IM02 in Patients with Advanced Solid Tumors Complicated by Malignant Pleural or Peritoneal Effusions' on June 26.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Patients with advanced solid tumors confirmed by histopathology or cytology (including but not limited to lung cancer, gastric cancer, ovarian cancer, breast cancer, pancreatic cancer, etc.).
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enr...